“…Once again, Mx seems to have the strongest body of evidence supporting its association with outcomes with studies consistently finding that a higher Mx was associated with poor or unfavourable outcome at follow up (Czosnyka et al, 1996;Czosnyka et al, 1997;Czosnyka et al, 1999;Czosnyka et al, 2000;Czosnyka et al, 2001;Czosnyka et al, 2002;Czosnyka et al, 2008;Lang et al, 2003a;Lewis et al, 2007;Lewis et al, 2012;Radolovich et al, 2011;Sorrentino et al, 2011;Budohoski et al, 2012a;Budohoski et al, 2012c;Liu et al, 2015;Schmidt et al, 2016a). When Mx was found to not be associated with outcomes, it was often attributed to small sample sizes (Schmidt et al, 2016b;Zeiler et al, 2017b). Those with a favourable outcome had a lower mean Mx (−0.06 ± 0.26 vs. 0.15 ± 0.31, p < 0.00002), lower mean ICP (17.0 ± 8.9 vs. 23.0 ± 13, p < 0.003), higher GCS on admission (6 vs. 4, p < 0.0018) Mx (r −0.2592, p < 0.0001), PRx (r 0.278, p < 0.0001), ICP (r −0.195, p < 0.01) and GCS (r −0.18, p < 0.014) were all correlated with 6-month GOS Thresholds of Mx (0.23) and PRx (0.31) were found by identifying where the Absolute left to right difference in Mx was correlated with Mx (mean left-right) (r 0.24, p < 0.025) Asymmetry was higher in those that died than survived (0.14 ± 0.18 vs. 0.08 ± 0.1, p 0.04) Mx was higher in those that died (0.13 ± 0.05 vs. −0.03 ± 0.05, p 0.002) By multiple regression analysis outcome was independently correlated with asymmetry of Mx (p < 0.0015) Hemispheric asymmetry in Mx was independently associated with outcome following TBI Single institution dataset Schmidt et al (2009) Primary: The assess if Mx/Mx_a were different during increases of CPP than during decreases of CPP Mx was significantly different during increases of CPP than during decreases of CPP (0.05 ± 0.49 vs. 0.14 ± 0.54, p < 0.005) Mx_a was not significantly different during increases in CPP compared to decreases in CPP Cerebrovascular reactivity, as measured by Mx, appears to be stronger during increases in CPP than during decreases in CPP During analysis, a large proportion of data was discarded with data from 53 out of 210 patients used in the study Schmidt et al (2012) Primary: To evaluate if cerebrovascular reactivity differs during increases in CPP as compared to decreases in CPP Cerebrovascular reactivity, as measured by Mx, was stronger during increases in CPP compared to decreases in CPP (0.06 ± 0.52 vs. 0.15 ± 0.55, p...…”